Advanced Search

 

Study ID Status Title Patient Level Data
111849 Completed A randomised, double-blind, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamic effects of 10 days of repeat dosing of GSK1521498 in overweight or obese but otherwise healthy subjects. Study Listed on ClinicalStudyDataRequest.com
111850 Completed A 35-Day, Multi-Centre, Randomised, Parallel-Group, Double-Blind, Placebo-Controlled Proof of Concept Study to Investigate the Effects of GSK1521498 on Body Weight and Composition, Eating Behaviour and Related Brain Function, in Obese Subjects with Over-Eating Behaviours. Study Listed on ClinicalStudyDataRequest.com
111852 Completed Immunogenicity and safety study of Kinrix® co-administered with Varivax® Study Listed on ClinicalStudyDataRequest.com
111853 Completed An Open Label, Non-Randomized, Single dose, Mass Balance Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1349572 20 mg, Administered as a Single Oral Suspension Dose to Healthy Adult Subjects (ING111853)
111854 Completed Phase I, Open Label, Randomized, Drug-Drug Interaction Study in Healthy Subjects to Investigate the Effects of Co-administered Atazanavir/Ritonavir (300mg/100mg) or Atazanavir 400mg Administered Once Daily on the Steady-State Plasma Pharmacokinetics of GSK1349572 30mg Administered Once Daily
111855 Completed A Double-Blind study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Norgestimate and Ethinyl Estradiol when Co-administered with Dolutegravir in Healthy Adult Female Subjects
111856 Completed A Study to Evaluate the Effect of a Single 250 mg Oral Dose of GSK1349572 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram Compared to Placebo and a Single Oral Dose of Moxifloxacin (ING111856).
111870 Completed A phase II, randomized, observer blind, controlled, multicenter study to assess immunogenicity and antibody persistence following vaccination with GSK's candidate combined measles, mumps, and rubella vaccine (MMR) versus M-M-R® II as a first dose, both administered subcutaneously at 12-15 months of age, concomitantly with hepatitis A vaccine (HAV), varicella vaccine (VV) and pneumococcal conjugate vaccine (PCV) but at separate sites. Study Listed on ClinicalStudyDataRequest.com
111891 Completed An Evaluation of Lung Function and Symptoms in Patients with Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy
111892 Withdrawn Study GLP111892: Albiglutide Versus Placebo as Add-on to Intensified Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus
111913 Completed TPL111913, a Multi-centre, Open Label, Dose Ranging Phase II Study to Assess Efficacy, Safety and Pharmacokinetics of Eltrombopag in Japanese Thrombocytopenic Subjects with Chronic Liver Disease
111924 Completed A randomized, double-blind, placebo controlled, incomplete block, 3 way cross over study in subjects with allergic rhinitis to assess the effect of intranasal repeat doses of SB-705498 when administered alone or in conjunction with intranasal fluticasone propionate on the symptoms of rhinitis in the Vienna allergen challenge chamber Study Listed on ClinicalStudyDataRequest.com
111925 Completed A randomized, double blind, placebo controlled study to assessthe effect of intranasal single dose SB-705498 on the response tointranasal capsaicin challenge in non-allergic rhinitis patients Study Listed on ClinicalStudyDataRequest.com
111949 Completed HI FPV study: Using observational cohorts to monitor safety of fosamprenavir in patients with mild/moderate hepatic impairment
111950 Completed Fractures over time stratified by HIV infection and Antiretroviral Therapy (ART) exposure
111954 Completed Non-inferiority study of GSK Biologicals’ Pandemic influenza vaccine 1562902A. Study Listed on ClinicalStudyDataRequest.com
111955 Completed Safety study of GSK Biologicals’ human papillomavirus vaccine (GSK580299) in female American and Canadian subjects who had received control vaccine in study 580299/008
111960 Terminated AVANDIA CV Outcomes Study: Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) A Multicenter Randomized Double-Blind Placebo-Controlled Trial of a Thiazolidinedione or Placebo and of Vitamin D or Placebo In People With Type 2 Diabetes at Risk For Cardiovascular Disease Study Listed on ClinicalStudyDataRequest.com
111981 Active not recruiting Post-marketing study of ropinirole prolonged release tablets in Parkinson’s disease: Evaluation outcomes associated with long term use of Ropinirole-PR using the clinical practice research datalink (CPRD)
111982 Completed Post-marketing carcinogenicity study of Bupropion
111983 Completed Fluticasone propionate nasal spray (Flixonase) safety in patients with allergic rhinitis registered in the UK General Practice Research Database
112008 Completed A single-centre, open-label, sequential, cross-over study to examine the safety, tolerability and pharmacokinetics of 3 ascending single intravenous doses, a single 1000μg oral dose and a single 1000μg inhaled dose of GSK573719 in healthy male volunteers. Study Listed on ClinicalStudyDataRequest.com
112014 Completed An open-label, two period study to determine the excretion balance and pharmacokinetics of 14C-GSK573719, administered as single dose of an oral solution and an intravenous infusion, to healthy male adults Study Listed on ClinicalStudyDataRequest.com
112016 Completed Phase I study of GSK233705- A randomised, double blind, placebo-controlled, 2-parts study to investigate the safety, tolerability, and pharmacokinetics of single and repeat inhaled doses of GSK233705 from a novel dry powder device in healthy Japanese male subjects -
112017 Completed Phase I study of GW642444M- A randomized, double blind, placebo controlled, parallel-group, 7 day repeat dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of inhaled dose of GW642444M from a novel dry powder device in healthy Japanese male subjects - Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.